# Hans‐Henrik Parving

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hans-henrik-parving-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,794 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 85 |
| i10-index | 216 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5111749912 |
| Works | 302 |

## Researcher papers

Showing 12 of 17.

- [Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes](https://scholariq.org/papers/effect-of-a-multifactorial-intervention-on-mortality-in-type-2-diabetes/)
- [\[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes\].](https://scholariq.org/papers/effect-of-irbesartan-on-the-development-of-diabetic-nephropathy-in-patients-with/)
- [Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes](https://scholariq.org/papers/cardiorenal-end-points-in-a-trial-of-aliskiren-for-type-2-diabetes/)
- [Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/aliskiren-combined-with-losartan-in-type-2-diabetes-and-nephropathy/)
- [Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease](https://scholariq.org/papers/bardoxolone-methyl-in-type-2-diabetes-and-stage-4-chronic-kidney-disease/)
- [EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY](https://scholariq.org/papers/early-aggressive-antihypertensive-treatment-reduces-rate-of-decline-in-kidney/)
- [Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes](https://scholariq.org/papers/increased-urinary-albumin-excretion-endothelial-dysfunction-and-chronic-low/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)](https://scholariq.org/papers/proteinuria-and-other-markers-of-chronic-kidney-disease-a-position-statement-of/)
- [Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study](https://scholariq.org/papers/predictors-for-the-development-of-microalbuminuria-and-macroalbuminuria-in/)
- [Progression of diabetic nephropathy](https://scholariq.org/papers/progression-of-diabetic-nephropathy/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.